Volume 27, Number 9—September 2021
CME ACTIVITY - Research
Maternal Carriage in Late-Onset Group B Streptococcus Disease, Italy
Table 2
Culture | Preterm cases, n = 18 | Missed cases | Full-term cases, n = 80 | Missed cases | p value | Total cases, n = 98 |
---|---|---|---|---|---|---|
Cultures before delivery | ||||||
VR tested | 18 (100) | 0 | 80 (100) | 0 | NA | 98 (100) |
Positive culture | 8 (44.4) | 0 | 35 (43.8) | 0 | 0.83 | 43 (43.9) |
Urine tested | 18 (100) | 0 | 74 (92.5) | 6 | 0.51 | 92 (93.9) |
GBS bacteriuria† |
0 (0) |
0 |
2 (2.7) |
0 |
0.85 |
2 (2.2) |
Cultures at onset of LOD | ||||||
VR tested | 18 (100) | 0 | 80 (100) | 0 | NA | 98 (100) |
Positive culture | 7 (38.9) | 0 | 51 (63.8) | 0 | 0.09 | 58 (59.2) |
Urine tested | 18 (100) | 0 | 72 (90.0) | 8 | 0.36 | 90 (91.8) |
GBS bacteriuria† | 5 (27.8) | 0 | 12 (16.7) | 0 | 0.46 | 17 (18.9) |
Breast milk tested‡ | 15 (83.3) | 3 | 68 (85.0) | 12 | 0·85 | 83 (84.7) |
Positive culture† | 2 (13.3) | 0 | 15 (22.1) | 0 | 0.69 | 17 (20.5) |
*Values are no. (%) except as indicated. Samples were obtained during pregnancy (urine), at prenatal screening (VR), and at onset of LOD (urine, VR, and breast milk). GBS, group B Streptococcus; LOD, late-onset disease; NA, not assessable; VR, vaginal/rectal. †Percentage and significance are calculated based on the patients who were tested. ‡Among 18 preterm neonates, 7 were exclusively fed breast milk (1 positive culture), 7 were fed pump-extracted milk (1 positive culture), 2 were fed formula milk, 1 was fed mixed breastmilk (missing culture), and 1 was fed donor human milk. Among 80 full-term neonates, 58 were exclusively fed breast milk (14 positive cultures and 1 missing culture), and 10 were fed mixed breast milk (1 positive culture and 1 missing culture).